Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04115514 · ClinicalTrials.gov registry record · Phase 2
Treatment of ARDS With Instilled T3
A Phase 2 study of Thyroid and Pulmonary Edema, sponsored by University of Minnesota.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 68
- Enrollment target
- 2
- Study locations
NCT04115514 is a Phase 2 study of Thyroid and Pulmonary Edema that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 68 participants, below the 331-participant average among 5 other Thyroid trials with a reported enrollment target (79% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT04115514, a Phase 2 study of Thyroid and Pulmonary Edema, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 68 participants
- Enrollment target
- 2
- Study locations
Study Summary
It is hypothesized that instillation of Liothyronine Sodium (T3) into the airspace will be safe, well tolerated, and will increase alveolar fluid clearance and decrease inflammation in patients with ARDS, reflected in improved oxygenation index (OI) and oxygenation saturation index (OSI).
Conditions Studied
Interventions
- DRUG Liothyronine Sodium (T3+0.9% sodium chloride) modified formulation specifically for airway instillation.
- OTHER Non-intervention
Study Locations (2)
Minnesota
- M Health Fairview Southdale Hospital - Edina
- East Bank Hospital - M Health Fairview University of Minnesota Medical Center - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2020-03-30 |
| Est. Completion | 2026-10-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04115514
The ClinicalTrials.gov registry entry for NCT04115514 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 331-participant average among 5 other Thyroid trials with a reported enrollment target (79% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Thyroid appearing as the primary indexed condition, and to 2 interventions - of which Liothyronine Sodium (T3+0.9% sodium chloride) modified formulation specifically for airway instillation. is the first listed.
NCT04115514 reports 2 study locations spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT04115514 about?
NCT04115514 is a clinical study titled "Treatment of ARDS With Instilled T3". It is hypothesized that instillation of Liothyronine Sodium (T3) into the airspace will be safe, well tolerated, and will increase alveolar fluid clearance and decrease inflammation in patients with ARDS, reflected in improved oxygenation index (OI) and oxygenation saturation index (OSI).
What is the current status of trial NCT04115514?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 68 participants. The study started on 2020-03-30. Estimated completion is 2026-10-31.
What conditions does trial NCT04115514 study?
This clinical trial studies the following conditions: Thyroid, Pulmonary Edema, Lung Inflammation, ARDS, Human, Lung, Wet.
What interventions are being tested in trial NCT04115514?
The interventions under investigation include: Liothyronine Sodium (T3+0.9% sodium chloride) modified formulation specifically for airway instillation. (DRUG), Non-intervention (OTHER).
Who is sponsoring clinical trial NCT04115514?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04115514 being conducted?
This trial has 2 study locations across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thyroid
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Laser Ablation of Papillary Thyroid Microcarcinoma
ACTIVE NOT RECRUITING · Phase 2
-
Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors
RECRUITING
-
A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer
RECRUITING
-
A Gene Hunting Study for Familial Papillary Thyroid Cancer
ACTIVE NOT RECRUITING
-
Randomized Trial Comparing Performance of Molecular Markers for Indeterminate Thyroid Nodules
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.